124 related articles for article (PubMed ID: 35781730)
21. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
22. Norwegian population norms for the EQ-5D-5L: results from a general population survey.
Garratt AM; Hansen TM; Augestad LA; Rand K; Stavem K
Qual Life Res; 2022 Feb; 31(2):517-526. PubMed ID: 34272631
[TBL] [Abstract][Full Text] [Related]
23. Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.
Hamoy-Jimenez G; Kim R; Suppiah S; Zadeh G; Bril V; Barnett C
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i141-i149. PubMed ID: 32642740
[TBL] [Abstract][Full Text] [Related]
24. Impact of socio-demographic and clinical characteristics on functional disability and health-related quality of life in patients with rheumatoid arthritis: a cross-sectional study from Palestine.
Al-Jabi SW; Seleit DI; Badran A; Koni A; Zyoud SH
Health Qual Life Outcomes; 2021 Oct; 19(1):241. PubMed ID: 34645455
[TBL] [Abstract][Full Text] [Related]
25. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
[TBL] [Abstract][Full Text] [Related]
26. Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P.
Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Hino A; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Noto S; Shimozuma K
Qual Life Res; 2019 Sep; 28(9):2383-2391. PubMed ID: 31025290
[TBL] [Abstract][Full Text] [Related]
27. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life of patients with HIV/AIDS at a tertiary care teaching hospital in Ethiopia.
Belay YB; Ali EE; Sander B; Gebretekle GB
Health Qual Life Outcomes; 2021 Jan; 19(1):24. PubMed ID: 33468153
[TBL] [Abstract][Full Text] [Related]
29. EQ-5D-5L Slovenian population norms.
Prevolnik Rupel V; Ogorevc M
Health Qual Life Outcomes; 2020 Oct; 18(1):333. PubMed ID: 33028345
[TBL] [Abstract][Full Text] [Related]
30. The dual presence of frailty and locomotive syndrome is associated with a greater decrease in the EQ-5D-5L index.
Tanaka S; Ando K; Kobayashi K; Nakashima H; Seki T; Ishizuka S; Machino M; Morozumi M; Kanbara S; Ito S; Kanemura T; Ishiguro N; Hasegawa Y; Imagama S
Nagoya J Med Sci; 2021 Feb; 83(1):159-167. PubMed ID: 33727747
[TBL] [Abstract][Full Text] [Related]
31. The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome.
Sturkenboom R; Keszthelyi D; Brandts L; Weerts ZZRM; Snijkers JTW; Masclee AAM; Essers BAB
Qual Life Res; 2022 Apr; 31(4):1209-1221. PubMed ID: 34546554
[TBL] [Abstract][Full Text] [Related]
32. Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019.
Yamauchi T; Suka M
Environ Health Prev Med; 2023; 28():77. PubMed ID: 38057084
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires.
Sawada A; Hiragi S; Tamura H; Goto R; Matsuyama Y; Sakai K; Miyata H; Yanagita M; Kuroda T; Ogawa O; Kobayashi T
Transplant Proc; 2021 Apr; 53(3):881-884. PubMed ID: 33303208
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set.
Grochtdreis T; Dams J; König HH; Konnopka A
Eur J Health Econ; 2019 Aug; 20(6):933-944. PubMed ID: 31030292
[TBL] [Abstract][Full Text] [Related]
35. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
[TBL] [Abstract][Full Text] [Related]
36. Correlation of preference- and profile-based quality of life of Japanese oral cancer patients during the perioperative period measured using EQ-5D-5L and FACT-H&N.
Aoki T; Ota Y; Izawa K; Osawa Y; Seta S; Tsuda B
Int J Oral Maxillofac Surg; 2022 Aug; 51(8):992-999. PubMed ID: 34551875
[TBL] [Abstract][Full Text] [Related]
37. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
38. Health-Related Quality of Life Population Norms for Belize Using EQ-5D-5L.
Bailey H; Janssen MF; La Foucade A; Castillo P; Boodraj G
Value Health Reg Issues; 2022 May; 29():45-52. PubMed ID: 34801885
[TBL] [Abstract][Full Text] [Related]
39. EQ-5D-5L norms for the urban Chinese population in China.
Yang Z; Busschbach J; Liu G; Luo N
Health Qual Life Outcomes; 2018 Nov; 16(1):210. PubMed ID: 30409137
[TBL] [Abstract][Full Text] [Related]
40. Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings.
Shiroiwa T; Noto S; Fukuda T
Value Health; 2021 Aug; 24(8):1193-1202. PubMed ID: 34372985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]